EUVIMEDEUVIMED entdecken
Crossref

3737 Improving the appropriateness of inpatient polypharmacy reviews: a three-stage retrospective quality improvement project

3737 Verbesserung der Angemessenheit stationärer Polypharmazie-Reviews: ein dreistufiges retrospektives Qualitätssicherungsprojekt

E George, A Maini

Age and Ageing · 05.02.2026 · 55 (Supplement_1)

DOI: 10.1093/ageing/afaf368.067 ↗

Auf einen Blick

Bei 60 Fällen wurden Polypharmazie-Reviews vor und nach mehreren Systemmaßnahmen untersucht. Dokumentierte Deprescribing-Gespräche und Absetzungen nahmen zu; die Entlassungsmedikation blieb jedoch hoch.

Fragestellung

Lassen sich stationäre Polypharmazie-Reviews durch Systemmaßnahmen verbessern und die Zahl unangemessener Medikamente senken?

Methode

Retrospektive Datenerhebung an 3 Zeitpunkten mit Systemmaßnahmen; Auswertung aus dem Hospital Information System. Interventionen: wöchentliche Arzt-Pharmazeut:innen-Runden, elektronische Deprescribing-Alarme und Schulungen.

Ergebnisse

Dokumentierte Deprescribing-Gespräche stiegen von 0 % auf 45 % und 60 %. Abgesetzte reguläre Medikamente nahmen von 5,4 % auf 19,3 % und 28,6 % zu. Die Zahl der Entlassungsmedikamente blieb hoch.

Schlussfolgerung der Autor:innen

Systeminterventionen bei Frailty können die Polypharmazie-Reviews verbessern und die Zahl unangemessener Medikamente senken. Patientenzentrierte Medikamentenreviews sollen das Polypharmaziemanagement optimieren.

Kernaussagen

  • Deprescribing-Gespräche: 0 % → 45 % → 60 %
  • Abgesetzte reguläre Medikamente: 5,4 % → 19,3 % → 28,6 %
  • Entlassungsmedikation blieb trotz Interventionen hoch

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, online erschienen am 05.02.2026. Verfasst von E George und 1 weiteren Autor:innen.

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Inappropriate polypharmacy is the use of medications with no evidence-based indication, unmet treatment goals, high risk of adverse drug reactions, or when the patient is unwilling/unable to take treatment as intended. This is particularly concerning in geriatric care, due to increased risk of hospital admissions, adverse drug reactions and significant healthcare costs. To address these risks, clinicians should conduct patient-focused medication reviews. This project aimed to assess and improve polypharmacy reviews at Royal Albert Edward Infirmary, with a focus on reducing inappropriate polypharmacy and its associated risks.

Method

Data was collected retrospectively from September 2024, December 2024, and June 2025 (n = 60), using ‘Hospital Information System.’ Demographics included age, sex, clinical frailty score and primary diagnosis. Admission and discharge medications were reviewed, alongside anticholinergic effect on cognition (AEC) scores, documentation of medication changes, patient involvement and formal medication reviews. Interventions included weekly combined doctor-pharmacist ward rounds, electronic deprescribing alerts, and education sessions for doctors.

Results

Documented deprescribing discussions increased from 0% (baseline Sept 24) to 45% (Dec 24) and then 60% (Jun 24). The proportion of regular medications discontinued rose from 5.4% to 19.3% to 28.6% over the three cycles. Despite these efforts, on average, patients were discharged with a higher number of medications before intervention—initially 9.1 vs 10.3, then 11.2 vs 10.9 post intervention and higher again—9.6 vs 11.0 in cycle three. As a result, discharge AEC scores across cycles one, two and three reflected this, with a 15% increase, 5% decrease and 4% increase, respectively. Commonly deprescribed medications included anti-hypertensives and statins; commonly initiated medications included laxatives and vitamin supplements. Analgesia was often adjusted.

Conclusions

System interventions in frailty to promote polypharmacy reviews can reduce the number of inappropriate medications. Ultimately, patient centred medication reviews will optimise polypharmacy management, reduce harm and improve patient outcomes.

Zitieren

APA

George, E., & Maini, A. (2026). 3737 Improving the appropriateness of inpatient polypharmacy reviews: a three-stage retrospective quality improvement project. Age and Ageing, 55(Supplement_1). https://doi.org/10.1093/ageing/afaf368.067

Vancouver

George E, Maini A. 3737 Improving the appropriateness of inpatient polypharmacy reviews: a three-stage retrospective quality improvement project. Age and Ageing. 2026;55(Supplement_1). doi:10.1093/ageing/afaf368.067

BibTeX
@article{George2026,
  author = {George, E and Maini, A},
  title = {3737 Improving the appropriateness of inpatient polypharmacy reviews: a three-stage retrospective quality improvement project},
  journal = {Age and Ageing},
  year = {2026},
  volume = {55},
  number = {Supplement_1},
  doi = {10.1093/ageing/afaf368.067}
}
Kostenlos starten →